Semax

Semax — Synthetic Heptapeptide Derived from ACTH(4-7)

Semax is a synthetic heptapeptide composed of the 4-7 fragment of adrenocorticotropic hormone (ACTH) coupled to the tripeptide Pro-Gly-Pro, which gives it metabolic stability far greater than the native sequence. Developed in Russian research institutes, it is the subject of a broad body of preclinical literature on neurotrophic factors (including BDNF), synaptic plasticity and the neuronal response to oxidative stress in laboratory models.

What it is studied for

In the published preclinical literature, Semax has been investigated in laboratory and in-vitro models for its effects on:

• Cognition, memory & focus — improved performance in learning and attention models
• Neurotrophic factors — up-regulation of BDNF and NGF
• Neuroprotection — protection against ischaemic and oxidative stress
• Synaptic plasticity — mechanisms that underlie learning and memory

In plain terms: a nootropic peptide studied for cognitive performance and neuroprotection.

Molecular Profile

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Molecular weight: ~813 Da
• Purity: ≥98% (HPLC)
• Format: Sterile lyophilizate in a 10 mg vial

Storage Conditions

• Store at -20 °C, protected from light
• After reconstitution: store at 2–8 °C and use within 28 days

Legal Disclaimer: Reagent intended exclusively for in vitro scientific research by qualified professionals. Not intended for human or veterinary consumption, nor for any therapeutic, diagnostic, or cosmetic purpose. This product is not a medicine, food supplement, or cosmetic. Nexus Peptides accepts no responsibility for any use outside the scope of laboratory research.